Join the Society of Surgical Oncology (SSO) on Monday, May 4, at 5 PM CDT or 6 PM EST for a virtual tumor board to discuss the current state of surgery for peritoneal surface disease. Click here to register and join: http://SSO.informz.net/z/cjUucD9taT03OTE0NTY0JnA9MSZ1PTc4OTM4MjI2NSZsaT02NTMxOTUzMA/index.html
Panelists from across the country will provide an update on the current state of COVID-19 and cover current practices in the management of peritoneal surface malignancies during the time of COVID-19. The following case will be discussed: Moderately differentiated appendiceal adenocarcinoma with peritoneal spread (PMCA-I, intermediate grade carcinoma peritonei after completing 12 cycles of FOLFOX).
This virtual tumor board discussion will include:
* Approaches to pre-operative testing
* Understanding the landscape of management of PSM during COVID-19 in the US
* How long it is safe to keep patients on chemotherapy who are CRS/HIPEC candidates
* Analyzing and interpreting risks of chemotherapy during COVID-19
Moderators for this virtual tumor board are Kiran Turaga, MD, MPH, University of Chicago and Edward Levine, MD, Wake Forest Baptist Health. Panelists include Joel Baumgartner, MD, UC San Diego Health, Laura Lambert, MD, University of Utah Health, Daniel Labow, MD, Mount Sinai St. Luke’s and Blasé Polite, MD, University of Chicago.